merestinib

merestinib
Trade Name
Orphan Indication Biliary tract cancer
USA Market Approval USA
USA Designation Date 2017-04-10 00:00:00
Sponsor Eli Lilly and Company;Lilly Corporate Center;Indianapolis, Indiana, 46285